Full-Time

Senior Medical Science Liaison

Dermatology

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

Compensation Overview

$133k - $209k/yr

+ Short-term Incentives + Long-term Incentives

Senior

Los Angeles, CA, USA + 2 more

More locations: Phoenix, AZ, USA | San Diego, CA, USA

Candidates must be based in California or Arizona.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Doctoral degree in life/health sciences is preferred (PharmD, MD, PhD, or equivalent), Master’s degree in health sciences (MSN, NP or PA) is the minimum requirement.
  • Minimum of 2 years of experience post-doctorate as a field-based medical science liaison (MSL) in the pharmaceutical industry is required.
  • Excellent communication (written and verbal), organization and collaboration skills are required.
  • Execution of activities within legal, regulatory, and compliance requirements.
Responsibilities
  • Externally-focused KOL/HCP related activities are expected to comprise a minimum of 80% of responsibilities.
  • Build and maintain professional relationships with KOLs/HCPs per individual territory plans aligned to medical strategy.
  • Demonstrate advanced knowledge regarding Takeda disease areas and products as well as therapeutic area competitor landscape; analyze and interpret complex scientific information and communicate to KOLs/HCPs in a compliant, fair-balanced, and non-misleading manner.
  • Support Takeda-sponsored research and appropriately assist with facilitation of strategically aligned medical collaborative studies and investigator-initiated research processes.
  • Display advanced knowledge of therapeutic area key intelligence topics/questions and effectively collect, interpret, and internally communicate medical insights from KOLs/HCPs to inform and refine medical strategies and/or tactics.
  • Identify and cultivate partnership opportunities between KOLs/HCPs and Takeda US Medical.
  • Participate in executing medical strategy at medical conferences (e.g., staff medical booth, internally communicate medical insights acquired through poster/session attendance and KOL/HCP interactions).
  • Within defined timelines and quality standards, respond to unsolicited HCP medical information inquiries referred by Medical Information.
  • Complete all required customer activity documentation (e.g., CRM entries, insights capture, etc.), training, expense reporting, and other administrative responsibilities in a timely, accurate, and compliant manner.
Desired Qualifications
  • Dissemination of complex scientific data to healthcare audiences.
  • Relevant therapeutic area knowledge and expertise.
  • Clinical, research, and/or teaching experience.
  • Ability to work effectively in virtual and cross-functional teams.
  • Execution of activities within legal, regulatory, and compliance requirements.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline aiming for multiple product launches in the coming years. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene could enhance its immunology and neurology offerings.
  • The SEA AtM Summit highlights Takeda's commitment to expanding access to medicines in Asia.
  • Positive Phase III trial results for a cancer drug strengthen Takeda's oncology portfolio.

What critics are saying

  • Antitrust litigation in the US could impact Takeda's market position and reputation.
  • The $770 million deal with BridGene poses financial risks if outcomes aren't met.
  • Geopolitical risks could disrupt Takeda's global operations and supply chain.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and innovations.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Nyasa Times
Feb 6th, 2025
Forgotten Children: Mzimba's Tukuyu CBCC Struggles to Provide Basic Education

VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...